Therefore, the effects of apoA-IV deficiency on energy and glucose metabolisms in the DO mice should be further pursued, and the findings from the inbred and outbred apoA-IV−/− mice will stimulate future research in individualized treatments of obesity and diabetes in humans in the era of precision medicine. This evidence concerns the gene APOA4 and obesity disorder.